regeneron pharmaceuticals market cap 2010

On December 31, 2010, Regeneron Pharmaceuticals (REGN) had a market capitalization of $2.8B, based on 87.41M shares at a price of $32.56.

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
December 31 2010
$32.56
329,600
87,405,000
$2,846,002,945.50
December 30 2010
$33.11
380,600
87,405,000
$2,893,682,373.00
December 29 2010
$33.05
396,200
87,405,000
$2,888,481,775.50
December 28 2010
$33.23
294,300
87,405,000
$2,904,083,568.00
December 27 2010
$33.41
280,500
87,405,000
$2,920,550,670.00
December 23 2010
$33.23
358,800
87,405,000
$2,904,083,568.00
December 22 2010
$33.20
405,600
87,405,000
$2,901,478,899.00
December 21 2010
$33.37
399,700
87,405,000
$2,917,080,691.50
December 20 2010
$32.79
750,600
87,405,000
$2,865,940,026.00
December 17 2010
$32.79
1,362,800
87,405,000
$2,865,940,026.00
December 16 2010
$31.77
509,500
87,405,000
$2,776,647,078.00
December 15 2010
$31.46
754,200
87,405,000
$2,749,778,781.00
December 14 2010
$30.36
443,400
87,405,000
$2,653,554,616.50
December 13 2010
$30.41
434,000
87,405,000
$2,657,881,164.00
December 10 2010
$29.95
380,700
87,405,000
$2,618,007,003.00
December 09 2010
$29.85
585,300
87,405,000
$2,609,336,427.00
December 08 2010
$29.84
387,700
87,405,000
$2,608,471,117.50
December 07 2010
$30.07
608,000
87,405,000
$2,628,408,198.00
December 06 2010
$29.89
490,800
87,405,000
$2,612,806,405.50
December 03 2010
$29.73
747,400
87,405,000
$2,598,935,232.00
December 02 2010
$29.24
846,000
87,405,000
$2,555,591,092.50
December 01 2010
$29.25
748,200
87,405,000
$2,556,456,402.00
November 30 2010
$28.58
581,500
87,405,000
$2,498,375,779.50
November 29 2010
$28.45
582,700
87,405,000
$2,486,243,965.50
November 26 2010
$28.59
185,900
87,405,000
$2,499,241,089.00